Tests could help predict Alzheimer’s disease progression

The study published online by Neurology found people who showed abnormal results on a PET brain scan which detects metabolic abnormalities and episodic memory tests were nearly 12 times more likely to develop Alzheimer's disease.

Alzheimer's Society comment:

'We don't currently know which people with MCI will go on to develop Alzheimer's disease. This important study moves us a step closer to unravelling this mystery. The tests identified could have real benefits in our search for a cause or cure for the disease, helping researchers identify suitable participants for drug trials.'

'At this stage it is a leap too far to say these tests can have immediate benefits for routine diagnosis. They are currently too expensive and the prognosis of Alzheimer's they provide is not 100 per cent guaranteed. We need more investment into research and treatment if we are to move our knowledge forward and improve the lives of people with dementia.'    

Dr Susanne Sorensen
Head of Research
Alzheimer's Society

- Ends -

Notes to editors:

• One in three people over 65 will die with dementia.
• Alzheimer's Society research shows that 750,000 people in the UK have a form of dementia, more than half have Alzheimer's disease. In just 15 years a million people will be living with dementia. This will soar to 1.7 million people by 2051.
• Alzheimer's Society champions the rights of people living with dementia and the millions of people who care for them. 
• Alzheimer's Society works in England, Wales and Northern Ireland.
• Alzheimer's Society supports people to live well with dementia today and funds research to find a cure for tomorrow. We rely on voluntary donations to continue our vital work. You can donate now by calling 0845 306 0898 or visiting alzheimers.org.uk
  
• Alzheimer's Society provides a National Dementia Helpline, the number is 0845 300 0336 or visit alzheimers.org.uk